CHRONIC GRAFT VERSUS HOST DISEASE
Clinical trials for CHRONIC GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy tested for tough transplant complication
Disease control CompletedThis study tested whether adding a drug called Interleukin-2 (IL-2) to a standard light-based blood treatment (ECP) could help control chronic graft-versus-host disease (GVHD) in adults. The 25 participants had GVHD that did not improve with steroid medications. They received ECP…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for kids battling transplant complications
Disease control CompletedThis study aimed to find a safe and effective dose of the drug ibrutinib for children and young adults with chronic graft-versus-host disease (cGVHD), a serious complication that can occur after a stem cell transplant. It involved 59 participants aged 1 to 22 years who had modera…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Pharmacyclics LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug tested for tough transplant complication
Disease control CompletedThis study tested an experimental drug called axatilimab for people with chronic graft-versus-host disease (cGVHD) that hadn't improved after at least two previous treatments. The trial aimed to find a safe dose and see if the drug could help control the disease. It involved 41 p…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC